Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity.

Manise M, Bakayoko B, Schleich F, Corhay JL, Louis R.

Int J Clin Pract. 2016 Jul;70(7):596-605. doi: 10.1111/ijcp.12837. Epub 2016 Jun 28.

2.

[Asthma-COPD overlap syndrome among patients with stable COPD].

Nguyen MS, Nguyen Dang D, Schleich F, Manise M, Corhay JL, Louis R.

Rev Med Liege. 2015 Jan;70(1):37-43. French.

PMID:
25902605
3.

Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).

Schleich F, Brusselle G, Louis R, Vandenplas O, Michils A, Pilette C, Peche R, Manise M, Joos G.

Respir Med. 2014 Dec;108(12):1723-32. doi: 10.1016/j.rmed.2014.10.007. Epub 2014 Oct 27.

4.

Importance of concomitant local and systemic eosinophilia in uncontrolled asthma.

Schleich FN, Chevremont A, Paulus V, Henket M, Manise M, Seidel L, Louis R.

Eur Respir J. 2014 Jul;44(1):97-108. doi: 10.1183/09031936.00201813. Epub 2014 Feb 13.

5.

Sputum IgE and cytokines in asthma: relationship with sputum cellular profile.

Manise M, Holtappels G, Van Crombruggen K, Schleich F, Bachert C, Louis R.

PLoS One. 2013;8(3):e58388. doi: 10.1371/journal.pone.0058388. Epub 2013 Mar 26.

6.

Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.

Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R.

BMC Pulm Med. 2013 Feb 26;13:11. doi: 10.1186/1471-2466-13-11.

7.

Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics.

Kuipers I, Louis R, Manise M, Dentener MA, Irvin CG, Janssen-Heininger YM, Brightling CE, Wouters EF, Reynaert NL.

Eur Respir J. 2013 Feb;41(2):469-72. doi: 10.1183/09031936.00115212. No abstract available.

8.

Is FENO50 useful diagnostic tool in suspected asthma?

Schleich FN, Asandei R, Manise M, Sele J, Seidel L, Louis R.

Int J Clin Pract. 2012 Feb;66(2):158-65. doi: 10.1111/j.1742-1241.2011.02840.x.

PMID:
22257040
9.

Disturbed cytokine production at the systemic level in difficult-to-control atopic asthma: evidence for raised interleukin-4 and decreased interferon-γ release following lipopolysaccharide stimulation.

Manise M, Schleich F, Quaedvlieg V, Moermans C, Henket M, Sele J, Corhay JL, Louis R.

Int Arch Allergy Immunol. 2012;158(1):1-8. doi: 10.1159/000329858. Epub 2011 Dec 28.

PMID:
22205180
10.

Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.

Moermans C, Heinen V, Nguyen M, Henket M, Sele J, Manise M, Corhay JL, Louis R.

Cytokine. 2011 Nov;56(2):298-304. doi: 10.1016/j.cyto.2011.07.010. Epub 2011 Aug 30.

PMID:
21880505
11.

[Inertia and adherence as factors influencing asthma control].

Louis R, Manise M, Sele J, Schleich F.

Rev Med Liege. 2010 May-Jun;65(5-6):338-42. French.

PMID:
20684416
12.

Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma.

Schleich FN, Seidel L, Sele J, Manise M, Quaedvlieg V, Michils A, Louis R.

Thorax. 2010 Dec;65(12):1039-44. doi: 10.1136/thx.2009.124925. Epub 2010 Jul 29.

PMID:
20671307
13.

Cytokine production from sputum cells and blood leukocytes in asthmatics according to disease severity.

Manise M, Schleich F, Gusbin N, Godinas L, Henket M, Antoine N, Corhay JL, Louis R.

Allergy. 2010 Jul;65(7):889-96. doi: 10.1111/j.1398-9995.2009.02296.x. Epub 2010 Jan 28.

14.

[Omralizumab (Xolair) in severe persistent allergic asthma].

Schleich F, Manise M, Louis R.

Rev Med Liege. 2009 May-Jun;64(5-6):313-7. French.

PMID:
19642466
15.

[Refractory asthma: underlying mechanisms, diagnosis and new therapeutic approach].

Manise M, Louis R.

Rev Med Liege. 2008 Jul-Aug;63(7-8):494-9. French.

PMID:
18771228

Supplemental Content

Loading ...
Support Center